eFFECTOR Therapeutics, Inc. has announced its Annual Meeting of Stockholders to be held virtually on June 13, 2024. The meeting will be accessible online with registration required by June 12, 2024. The agenda includes the election of two Class III directors, Elizabeth P. Bhatt and Barbara Klencke, M.D., for a three-year term expiring in 2027. Additionally, stockholders will vote on the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and on a proposal to amend the Amended and Restated Certificate of Incorporation to increase the authorized shares of common stock from 40 million to 80 million. The Board of Directors recommends a vote in favor of all the proposals. The proxy materials are available online, and stockholders are encouraged to review them before voting. Requests for paper or e-mail copies of the proxy materials must be made by June 4, 2024.

eFFECTOR Therapeutics, Inc. has announced its Annual Meeting of Stockholders to be held virtually on June 13, 2024. The meeting will be accessible online with registration required by June 12, 2024. The agenda includes the election of two Class III directors, Elizabeth P. Bhatt and Barbara Klencke, M.D., for a three-year term expiring in 2027. Additionally, stockholders will vote on the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and on a proposal to amend the Amended and Restated Certificate of Incorporation to increase the authorized shares of common stock from 40 million to 80 million. The Board of Directors recommends a vote in favor of all the proposals. The proxy materials are available online, and stockholders are encouraged to review them before voting. Requests for paper or e-mail copies of the proxy materials must be made by June 4, 2024.